{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:00:31Z","timestamp":1781078431071,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd012351","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000}}],"reference-count":118,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012351.pub2","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T13:00:21Z","timestamp":1500642021000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Histologic scoring indices for evaluation of disease activity in Crohn\u2019s disease"],"prefix":"10.1002","volume":"2017","author":[{"given":"Gregor","family":"Novak","sequence":"first","affiliation":[{"name":"Academic Medical Center, University of Amsterdam; Department of Gastroenterology; Amsterdam Netherlands"},{"name":"University Medical Centre; Department of Gastroenterology and Hepatology; Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E","family":"Parker","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rish K","family":"Pai","sequence":"additional","affiliation":[{"name":"Mayo Clinic; Department of Pathology; Scottsdale AZ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"},{"name":"University of Western Ontario; Department of Medicine; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G","family":"Feagan","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"},{"name":"University of Western Ontario; Department of Medicine; London ON Canada"},{"name":"University of Western Ontario; Department of Epidemiology and Biostatistics; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Sandborn","sequence":"additional","affiliation":[{"name":"University of California San Diego; Division of Gastroenterology; La Jolla CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"D'Haens","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Meibergdreef 9 - C2-112 Amsterdam Netherlands 1105 AZ"},{"name":"Robarts Clinical Trials; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[{"name":"University of Western Ontario; Department of Medicine; London ON Canada"},{"name":"University of Western Ontario; Department of Epidemiology and Biostatistics; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Khanna","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"},{"name":"University of Western Ontario; Department of Medicine; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2036.2003.01487.x","article-title":"Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease","volume":"17","author":"Agnholt","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(99)70224-6","article-title":"Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis","volume":"116","author":"Baert","year":"1999","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0016-5085(99)70005-3","article-title":"Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial","volume":"116","author":"D'Haens","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00330-008-1290-5","article-title":"Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn's disease","volume":"19","author":"Drews","year":"2009","journal-title":"European Radiology"},{"issue":"11","key":"10.1002\/14651858.CD012351.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1185\/030079905X65457","article-title":"Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease","volume":"21","author":"Geboes","year":"2005","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gut.27.1.92","article-title":"Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease","volume":"27","author":"Gomes","year":"1986","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2036.2010.04569.x","article-title":"Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab","volume":"33","author":"Laharie","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD012351.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ibd.20777","article-title":"Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease","volume":"15","author":"Mantzaris","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"issue":"12","key":"10.1002\/14651858.CD012351.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.humpath.2012.03.008","article-title":"A histopathologic scoring system as a tool for standardized reporting of chronic (ileo)colitis and independent risk assessment for inflammatory bowel disease","volume":"43","author":"Naini","year":"2012","journal-title":"Human Pathology"},{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(10)61651-4","article-title":"Correlation of histologic and endoscopic scores for evaluation of Crohn's disease recurrence after ileal resection and infliximab therapy","volume":"138","author":"Regueiro","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.gastro.2008.10.051","article-title":"Infliximab prevents Crohn's disease recurrence after ileal resection","volume":"136","author":"Regueiro","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD012351.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2008.03835.x","article-title":"Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings","volume":"28","author":"Sipponen","year":"2008","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S-85, S-86","DOI":"10.1016\/S0016-5085(10)60391-5","article-title":"Naltrexone therapy improves activity and promotes mucosal healing in active Crohn's disease: A placebo-controlled trial","volume":"138","author":"Smith","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD012351.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s10620-011-1653-7","article-title":"Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial","volume":"56","author":"Smith","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jcp.30.2.126","article-title":"Rectal biopsy as a prognostic guide in Crohn's colitis","volume":"30","author":"Ward","year":"1977","journal-title":"Journal of Clinical Pathology"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.MIB.0000161307.58327.96","article-title":"Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings","volume":"11","author":"Yamamoto","year":"2005","journal-title":"Inflammatory Bowel Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012351.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000364912","article-title":"Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis","volume":"22","author":"Abad","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/gut.2003.037085","article-title":"Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity","volume":"54","author":"Ajaj","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10620-006-9515-4","article-title":"Colonic ornithine decarboxylase in inflammatory bowel disease: ileorectal activity gradient, guanosine triphosphate stimulation, and association with epithelial regeneration but not the degree of inflammation and clinical features","volume":"52","author":"Allgayer","year":"2007","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/gut.29.11.1531","article-title":"Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease","volume":"29","author":"Allison","year":"1988","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD012351.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2036.2000.00802.x","article-title":"Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease","volume":"14","author":"Ang","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.crohns.2010.07.011","article-title":"A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: Results from a randomized controlled trial","volume":"4","author":"Baars","year":"2010","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S776","DOI":"10.1016\/S0016-5085(11)63221-6","article-title":"The majority of patients with inflammatory bowel disease in clinical remission has mucosal inflammation","volume":"1","author":"Baars","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD012351.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ibd.21925","article-title":"Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation","volume":"18","author":"Baars","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1440-1746.2002.02564.x","article-title":"Thalidomide for inflammatory bowel disease: Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease","volume":"17","author":"Bariol","year":"2002","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2036.1994.tb00338.x","article-title":"Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease","volume":"8","author":"Beattie","year":"1994","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0027|cit27","first-page":"S693","article-title":"Azathioprine (AZA) is associated with less histological inflammation of the colon in clinically inactive IBD","volume":"1","author":"Bergeron","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD012351.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.dld.2008.01.017","article-title":"Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease","volume":"40","author":"Berni Canani","year":"2008","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0029|cit29","first-page":"908","article-title":"Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease","volume":"88","author":"Bernstein","year":"1993","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/00365521.1970.12096647","article-title":"A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis","volume":"5","author":"Binder","year":"1970","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0031|cit31","first-page":"S34","article-title":"Fecal calprotectin is reliable surrogate marker of endoscopic and histologic mucosal healing in Crohn's disease and ulcerative colitis","volume":"5","author":"Bojic","year":"2011","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1590-8658(02)80056-1","article-title":"Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?","volume":"34","author":"Borody","year":"2002","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2036.1995.tb00419.x","article-title":"The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease","volume":"9","author":"Breese","year":"1995","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/PL00000246","article-title":"Increased expression of metallothionein in inflammatory bowel disease","volume":"50","author":"Bruwer","year":"2001","journal-title":"Inflammation Research"},{"issue":"11","key":"10.1002\/14651858.CD012351.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/j.1572-0241.2007.01537.x","article-title":"Correlation of CT enteroclysis with surgical pathology in Crohn's disease","volume":"102","author":"Chiorean","year":"2007","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1016\/S0016-5085(11)61729-0","article-title":"Fecal calproctectin is strongly predictive of clinical disease activity and histological severity in inflammatory bowel disease","volume":"1","author":"Chung-Faye","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/S1873-9946(14)60340-8","article-title":"Fecal calprotectin is an accurate predictor of endoscopic and histological disease activity in IBD","volume":"8","author":"Chung-Faye","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gut.2005.084301","article-title":"Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein","volume":"55","author":"Colombel","year":"2006","journal-title":"Gut"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0039|cit39","first-page":"21","article-title":"Histological damage correlates with the number of HIF-2 positive cells in the lamina propria of patients with inflammatory bowel disease","volume":"109","author":"Cosin","year":"2011","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0016-5085(97)70027-1","article-title":"Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease","volume":"112","author":"D'Haens","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum","volume":"114","author":"D'Haens","year":"1998","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD012351.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1111\/j.1572-0241.2001.04705.x","article-title":"Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial","volume":"96","author":"D'Haens","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jim-50-06-02","article-title":"Expression of the regenerating gene family in inflammatory bowel disease mucosa: Reg Ialpha upregulation, processing, and antiapoptotic activity","volume":"50","author":"Dieckgraefe","year":"2002","journal-title":"Journal of Investigative Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012351.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/MEG.0b013e3283293d0f","article-title":"Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn's disease patients treated with infliximab","volume":"21","author":"Sabatino","year":"2009","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0045|cit45","first-page":"AB444","article-title":"Endoscopic ultrasound of the colon can differentiate between crohn's disease and ulcerative colitis and reliably quantifies the degree of inflammation - A prospective, blinded, and controlled comparative study","volume":"1","author":"Ellrichmann","year":"2012","journal-title":"Gastrointestinal Endoscopy"},{"issue":"8","key":"10.1002\/14651858.CD012351.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/apt.12671","article-title":"Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls","volume":"39","author":"Ellrichmann","year":"2014","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD012351.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00042737-199903000-00011","article-title":"Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group","volume":"11","author":"Ewe","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000658-199610000-00014","article-title":"Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial","volume":"224","author":"Fazio","year":"1996","journal-title":"Annals of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1053\/j.gastro.2006.02.025","article-title":"The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence","volume":"130","author":"Ferrante","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1572-0241.1999.01143.x","article-title":"Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease","volume":"94","author":"Folwaczny","year":"1999","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0029-1245398","article-title":"Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn's disease","volume":"32","author":"Girlich","year":"2011","journal-title":"Ultraschall in der Medizin"},{"issue":"26","key":"10.1002\/14651858.CD012351.pub2-BIB0052|cit52","first-page":"920","article-title":"Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease","volume":"46","author":"Griga","year":"1999","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7863\/jum.2002.21.4.375","article-title":"Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides","volume":"21","author":"Haber","year":"2002","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012351.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<304::AID-PATH375>3.0.CO;2-A","article-title":"Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core","volume":"188","author":"Hanski","year":"1999","journal-title":"Journal of Pathology"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gut.38.4.564","article-title":"Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation","volume":"38","author":"Hommes","year":"1996","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD012351.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1055\/s-0034-1391863","article-title":"Complete mucosal healing defined by endoscopic Mayo sub score still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings","volume":"47","author":"Iacucci","year":"2015","journal-title":"Endoscopy"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(15)32150-8","article-title":"Endoscopic assessment of mucosal healing in Crohn's disease by novel iSCAN endoscopic and refined histological gradings","volume":"148","author":"Iacucci","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD012351.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/gut.2006.113431","article-title":"Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome","volume":"56","author":"Kaiser","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF02213118","article-title":"Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings","volume":"41","author":"Kolkman","year":"1996","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1148\/radiol.2291020692","article-title":"Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy","volume":"229","author":"Koutroubakis","year":"2003","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/S1873-9946(13)60299-8","article-title":"Clinical comparison of eight different calprotectin immunoassays for the diagnosis and follow-up of inflammatory bowel disease","volume":"7","author":"Labaere","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1754-9485.2010.02223.x","article-title":"Relative efficacy of different MRI signs in diagnosing active Crohn's disease, compared against a histological gold standard","volume":"55","author":"Lasocki","year":"2011","journal-title":"Journal of Medical Imaging and Radiation Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01296291","article-title":"Indium-111-labeled autologous leukocyte imaging and fecal excretion. Comparison with conventional methods of assessment of inflammatory bowel disease","volume":"32","author":"Leddin","year":"1987","journal-title":"Digestive Diseases and Sciences"},{"issue":"12","key":"10.1002\/14651858.CD012351.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/ibd.22930","article-title":"Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: prospective comparison of 18F-FDG-PET\/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic\/histologic evaluation","volume":"18","author":"Lenze","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/1993\/982796","article-title":"Immunoglobulin therapy in inflammatory bowel disease","volume":"7","author":"Levine","year":"1993","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MCG.0b013e318248f289","article-title":"Fecal calprotectin in clinical practice: A noninvasive screening tool for patients with chronic diarrhea","volume":"46","author":"Licata","year":"2012","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0068|cit68","first-page":"A60","article-title":"Topical NFkB p65 antisense oligonucleotides in patients with active distal colonic IBD. A randomised, controlled pilot trial","volume":"122","author":"Lofberg","year":"2002","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD012351.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2036.2003.01673.x","article-title":"Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features","volume":"18","author":"Maconi","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/00054725-201212001-00151","article-title":"A novel mechanistic biomarker panel predicts response to infliximab in patients with Crohn's disease","volume":"18","author":"Macoritto","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/gut.38.1.99","article-title":"Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease","volume":"38","author":"Mahmud","year":"1996","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0072|cit72","first-page":"393","article-title":"The value of rectal biopsy in the diagnosis of ulcerative colitis","volume":"30","author":"Matts","year":"1961","journal-title":"QJM"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0073|cit73","first-page":"997","article-title":"Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation","volume":"144","author":"Mazzucchelli","year":"1994","journal-title":"American Journal of Pathology"},{"issue":"36","key":"10.1002\/14651858.CD012351.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.3748\/wjg.v18.i36.5065","article-title":"Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases","volume":"18","author":"Merra","year":"2012","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.gastro.2009.03.062","article-title":"Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease","volume":"137","author":"Migaleddu","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.crohns.2009.08.001","article-title":"Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?","volume":"3","author":"Molnar","year":"2009","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1590-8658(09)60474-6","article-title":"Non invasive stool markers in assessing bowel inflammation in children with inflammatory bowel disease","volume":"41S (S3)","author":"Neaga","year":"2009","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0078|cit78","first-page":"S54","article-title":"Virtual chromoendoscopy with i-scan for diagnosis of mucosal healing in patients with inflammatory bowel disease a prospective randomized double-blind controlled study","volume":"6","author":"Neumann","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ibd.23025","article-title":"Endocytoscopy allows accurate in vivo differentiation of mucosal inflammatory cells in IBD: a pilot study","volume":"19","author":"Neumann","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/adc.71.3.243","article-title":"Cyclosporin as initial treatment for Crohn's disease","volume":"71","author":"Nicholls","year":"1994","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/00365520310000672","article-title":"Upregulation of interleukin-12 and -17 in active inflammatory bowel disease","volume":"38","author":"Nielsen","year":"2003","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0082|cit82","first-page":"146A","article-title":"Ischemic pouchitis (IP): A histologic evaluation and comparison to Crohn's disease of the pouch (CDP) and antibiotic-responsive pouchitis (ARP)","volume":"89","author":"Plesec","year":"2009","journal-title":"Laboratory Investigation"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0016-5085(88)90174-6","article-title":"Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning","volume":"95","author":"Pullman","year":"1988","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.crohns.2012.03.002","article-title":"Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn's disease: a comparison with surgical histopathology analysis","volume":"7","author":"Ripolles","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0016-5085(86)90376-8","article-title":"Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal Indium 111-granulocyte excretion","volume":"90","author":"Saverymuttu","year":"1986","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1002\/14651858.CD012351.pub2-BIB0086|cit86","first-page":"1539","article-title":"Effect of short-term topical corticosteroid treatment on mucosal enzyme systems in patients with distal inflammatory bowel disease","volume":"45","author":"Scheurlen","year":"1998","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0344-0338(88)80156-0","article-title":"Relationships between blood chemistry and histology of the rectal mucosa in Crohn's disease","volume":"183","author":"Schmitz-Moormann","year":"1988","journal-title":"Pathology, Research and Practice"},{"issue":"8","key":"10.1002\/14651858.CD012351.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1055\/s-2001-16400","article-title":"Hydro-MRI in inflammatory bowel diseases: a comparison with colonoscopy and histology","volume":"173","author":"Schunk","year":"2001","journal-title":"RoFo"},{"issue":"10","key":"10.1002\/14651858.CD012351.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/gut.34.10.1364","article-title":"Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance","volume":"34","author":"Sciarretta","year":"1993","journal-title":"Gut"},{"issue":"12","key":"10.1002\/14651858.CD012351.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/gut.32.12.1514","article-title":"Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications","volume":"32","author":"Seldenrijk","year":"1991","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004836-199407000-00009","article-title":"Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease","volume":"19","author":"Shoenut","year":"1994","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD012351.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2967\/jnumed.110.080796","article-title":"Low-dose 18F-FDG PET\/CT enterography: improving on CT enterography assessment of patients with Crohn disease","volume":"51","author":"Shyn","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1203\/01.PDR.0000083002.91602.40","article-title":"Cytokine tissue levels as markers of disease activity in pediatric Crohn disease","volume":"54","author":"Silva","year":"2003","journal-title":"Pediatric Research"},{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00054725-200409000-00003","article-title":"Characterization and distribution of colonic dendritic cells in Crohn's disease","volume":"10","author":"Silva","year":"2004","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/bjs.1800820217","article-title":"Endoscopic and external bowel changes and histopathology in patients with Crohn's disease","volume":"82","author":"Smedh","year":"1995","journal-title":"British Journal of Surgery"},{"issue":"12","key":"10.1002\/14651858.CD012351.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00042737-199612000-00011","article-title":"The endoscopic picture reflects transmural inflammation better than endoscopic biopsy in Crohn's disease","volume":"8","author":"Smedh","year":"1996","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0016-5085(10)60391-5","article-title":"Naltrexone therapy improves activity and promotes mucosal healing in active Crohn's disease: A placebo-controlled trial","volume":"138","author":"Smith","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD012351.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/gut.33.9.1220","article-title":"Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients","volume":"33","author":"Sobhani","year":"1992","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD012351.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease","volume":"11","author":"Solem","year":"2005","journal-title":"Inflammatory Bowel Diseases"},{"issue":"9","key":"10.1002\/14651858.CD012351.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ejrad.2011.07.013","article-title":"Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index","volume":"81","author":"Steward","year":"2012","journal-title":"European Journal of Radiology"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1756-0500-2-221","article-title":"Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes","volume":"2","author":"Vieira","year":"2009","journal-title":"BMC Research Notes"},{"issue":"12","key":"10.1002\/14651858.CD012351.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/gut.33.12.1644","article-title":"Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease","volume":"33","author":"Wardle","year":"1992","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.2002.01242.x","article-title":"Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn\u2019s disease?","volume":"16","author":"Arnott","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0104|cit104","doi-asserted-by":"crossref","unstructured":"Bouguen G Levesque BG Feagan BG Kavanaugh A Peyrin-Biroulet L Colombel JF Treat to target: a proposed new paradigm for the management of Crohn's disease Clinical Gastroenterology and Hepatology 2015 1042 50","DOI":"10.1016\/j.cgh.2013.09.006"},{"issue":"10","key":"10.1002\/14651858.CD012351.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ibd.21034","article-title":"Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn\u2019s disease","volume":"15","author":"D\u2019Haens","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD012351.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"142S","DOI":"10.1016\/S0197-2456(05)80019-4","article-title":"Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation","volume":"12","author":"Deyo","year":"1991","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD012351.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2249.1998.00728.x","article-title":"Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines","volume":"114","author":"Dieleman","year":"1998","journal-title":"Clinical and Experimental Immunology"},{"issue":"3","key":"10.1002\/14651858.CD012351.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.47.3.404","article-title":"A reproducible grading scale for histological assessment of inflammation in ulcerative colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/S1873-9946(12)60502-9","article-title":"Changing Crohn\u2019s disease management: need for new goals and indices to prevent disability and improve quality of life","volume":"6","author":"Hommes","year":"2012","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0021-9681(85)90005-0","article-title":"A methodological framework for assessing health indices","volume":"38","author":"Kirshner","year":"1985","journal-title":"Journal of Chronic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012351.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-198404000-00005","article-title":"Response to drug therapy in Crohn's disease: evaluation by rectal biopsy and mucosal cell counts","volume":"6","author":"Korelitz","year":"1984","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"159-74","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"5","key":"10.1002\/14651858.CD012351.pub2-BIB0113|cit113","first-page":"511","article-title":"The histopathological approach to inflammatory bowel disease: a practice guide","volume":"464","author":"Langner","year":"2014","journal-title":"Virchows Archiv: an International Journal of Pathology"},{"issue":"11","key":"10.1002\/14651858.CD012351.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1097\/MIB.0000000000000155","article-title":"Assessment of histologic disease activity in Crohn's disease: a systematic review","volume":"20","author":"Mojtahed","year":"2014","journal-title":"Inflamm Bowel Diseases"},{"issue":"9","key":"10.1002\/14651858.CD012351.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.crohns.2012.10.018","article-title":"Achievement of deep remission during scheduled maintenance therapy with TNF \u03b1-blocking agents in IBD","volume":"7","author":"Molander","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD012351.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gutjnl-2015-310393","article-title":"Development and validation of a histological index for UC","volume":"66","author":"Mosli","year":"2017","journal-title":"Gut"},{"key":"10.1002\/14651858.CD012351.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","article-title":"Biopsy studies in ulcerative colitis","volume":"1","author":"Truelove","year":"1956","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD012351.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11136-004-0027-4","article-title":"Quantifying responsiveness of quality of life measures without an external criterion","volume":"14","author":"Zou","year":"2005","journal-title":"Quality of Life Research"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012351.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T09:03:58Z","timestamp":1684659838000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012351.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":118,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012351.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,21]]}}}